Merck & Co. Inc. | 2013 | FY | 3


Equity income from affiliates reflects the performance of the Company’s joint ventures and other equity method affiliates and was comprised of the following:
Years Ended December 31
2013
 
2012
 
2011
AstraZeneca LP
$
352

 
$
621

 
$
574

Other (1)
52

 
21

 
36

 
$
404

 
$
642

 
$
610

(1) Primarily reflects results from Sanofi Pasteur MSD and Johnson & Johnson°Merck Consumer Pharmaceuticals Company (which was disposed of on September 29, 2011).

us-gaap:EquityMethodInvestmentsTextBlock